Ascopubs.org - SEO Checker

Visión general del análisis SEO
Metadatos
75% 
Calidad de la página
74% 
Estructura
58% 
Enlazado
10% 
Servidor
86% 
Factores externos
100% 
Puntuación SEO
Tiempo de carga
1,15 s
Tamaño HTML
112,20 kB
Palabras
1297
Medios
22
Cantidad de enlaces
143 internos / 37 externos

Lista de tareas pendientes para mejorar tu SEO

Metadatos

Título
(Extremadamente importante)
ASCO Publications
El título es demasiado corto (174 píxeles de un máximo de 580 píxeles).Optimizar ahora
No se repite ninguna palabra en el título.
Meta descripción
(Extremadamente importante)
No se encuentra la meta descripción.
Rastreabilidad
(Extremadamente importante)
No se detectan problemas para acceder al sitio web.
Redirección canónica
(Importante)
https://ascopubs.org/
La página tiene una redirección canónica correcta.
Idioma
(Poco importante)
Idioma reconocido automáticamente en el contenido: en
Idioma declarado en el código HTML: en
Ubicación geográfica del servidor: Estados Unidos de América
El idioma ha sido correctamente declarado en el código HTML: en.
Enlaces Alternate/Hreflang
(Poco importante)
No se ha encontrado ningún enlace alternativo (alternate) en esta página.
Otras Metaetiquetas
(Poco importante)
No se detecta ninguna metaetiqueta de paginación rel next en la página.
No se detecta ninguna metaetiqueta de paginación rel prev en la página.
Dominio
(Poco importante)
El dominio no es un subdominio.
La longitud del nombre del dominio es buena.
El dominio no contiene caracteres especiales.
URL de la página
(Poco importante)
No se detecta ningún parámetro dinámico en la URL.
No se detecta ningún ID de sesión en la URL.
La URL no contiene demasiados subdirectorios.
Codificación de caracteres
(Poco importante)
La codificación de caracteres (UTF-8) ha sido declarada correctamente.
Doctype
(Deseable)
La etiqueta doctype HTML 5 está configurada correctamente.
La declaración del doctype se ubica al inicio del código HTML.
Favicon
(Deseable)
El favicon está enlazado correctamente.

Metaetiquetas

NombreValor
jcodeVacío
robotsnoarchive
viewportwidth=device-width,initial-scale=1
bchashVacío
pbContext;wgroup:string:Publication Websites;website:website:asco-site;page:string:Home Page
langen
og:titleASCO Publications
og:typeWebsite
og:site_nameAmerican Society of Clinical Oncology
X-UA-CompatibleIE=edge
charsetUTF-8

¡Analiza ya gratis hasta 1.000 páginas de ascopubs.org!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Calidad de la página

Contenido
(Extremadamente importante)
Solo se han encontrado 2 párrafos en esta página.
El número total de palabras en la página es bueno: 1297 palabras.
Un 20.2% del contenido está constituido por palabras vacías.
Las palabras clave del título también se repiten en el texto del cuerpo.
La página contiene un listado, lo que indica una buena estructuración del contenido.
No se detecta ningún placeholder de texto ni imagen.
No se detecta contenido duplicado.
La cantidad media de palabras por frase es buena: 22.5 palabras.
Frames
(Extremadamente importante)
Esta página no utiliza ningún frameset.
Optimización para móviles
(Poco importante)
No se ha especificado ningún icono de Apple Touch.
El valor de la etiqueta viewport es correcto: (width=device-width,initial-scale=1).
Etiquetas Bold y Strong
(Poco importante)
El uso de etiquetas de negritas en esta página es óptimo. Te recomendamos emplear hasta 26 etiquetas de negritas en una página.
Optimización de imágenes
(Poco importante)
No se detecta ninguna descripción del atributo ALT en 1 imágenes. El contenido de los atributos ALT también es evaluado como texto por los buscadores y es muy importante para la búsqueda de imágenes.
Redes Sociales
(Deseable)
Esta página apenas ofrece posibilidades de compartir el contenido en redes sociales. Con la integración de widgets puedes conseguir que tus contenidos se popularicen en redes.
Etiquetas markup adicionales
(Deseable)
No se detecta ninguna etiqueta markup (de Schema.org) adicional.
HTTPS
(Poco importante)
El sitio utiliza HTTPS para transferir datos de forma segura.
Todos los archivos incluidos se transfieren a través de HTTPS.

Estructura de la página

Encabezado H1
(Extremadamente importante)
American Society of Clinical Oncology (ASCO)
El encabezado H1 es óptimo.
Encabezados
(Importante)
Algunos de los encabezados H se repiten dos veces.
Hay 50 encabezados H en esta página. La cantidad de encabezados debería guardar una mejor proporción en relación al texto.

Estructura de los encabezados

Jerarquía de encabezadosContenido
H1 American Society of Clinical Oncology (ASCO)
H2 Latest from our Journals
H2 Podcasts
H2 A world where cancer is prevented or cured
H2 Our Journals
H2 Our Content
H2 Topics
H2 Submit to JCO Journals
H3 Reply to M. Boileau et al
H3 Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
H3 Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
H3 Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality
H3 Neoadjuvant Sonic Hedgehog Inhibitors Combined With Radiotherapy Is a Promising Strategy for Locally Advanced Basal Cell Carcinoma
H3 Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations
H3 Cureit: An End-to-End Pipeline for Implementing Mixture Cure Models With an Application to Liposarcoma Data
H3 Sex-based Differences in Risk for Therapy-related Myeloid Neoplasms
H3 Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
H3 Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
H3 Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
H3 Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overa...
H3 Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
H3 Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline
H3 Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
H3 Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
H3 Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
H3 How To Build and Interpret a Nomogram for Cancer Prognosis
H3 Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
H3 Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
H3 JCO PO Article Insights: Statistical Considerations for Biomarker-Driven Oncology Clinical Trials
H3 JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
H3 It Mattered Later: A Patient Turned Doctor's Perspective on Fertility Loss
H3 Management of Stage III NSCLC Rapid Update
H3 Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality Texto duplicado
H3 JCO Global Oncology Editorial on Resource-Stratified Guidelines
H3 Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement
H3 Three Days Was Enough
H3 Patterns of Survivorship Follow-Up Care Among Patients With Breast Cancer: A Retrospective Population-Based Cohort Study in Ontario, Canada, Between 2006 and 2016
H3 Fragmented Surgical Cancer Care—A Growing Divide
H3 Decision Analysis as an Aid to Determining the Management of Early Low Rectal Cancer for the Individual Patient
H3 Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric Cancer
H3 Recurrence Patterns of Hepatocellular and Fibrolamellar Carcinoma After Liver Transplantation
H4 Announcements
H4 ASCO Launches New Open Access Journal JCO Oncology Advances
H4 Stay on Top of Your Specialty with JCO Topics
H5 Volume 42Issue 22
H5 Volume 20Issue 7
H5 Volume 10
H5 Volume 8
H5 Volume 8 Texto duplicado
H6 Popular Searches:
Algunos textos ancla son demasiado largos.
Algunos enlaces internos contienen parámetros dinámicos. Las URL internas no deberían contener parámetros dinámicos, salvo que estén marcadas como nofollow.
Algunos textos ancla se repiten más de una vez en varios enlaces.
La cantidad de enlaces internos es adecuada.
Hay demasiados enlaces externos (37) en esta página.
EnlacePropiedadesTexto ancla
https://ascopubs.org/Texto ancla Skip to main content
https://ascopubs.org/IMG-ALT ASCO Publications
https://ascopubs.org/journal/jcoJournal of Clinical Oncology
https://ascopubs.org/journal/opJCO Oncology Practice
https://ascopubs.org/journal/goJCO Global Oncology
https://ascopubs.org/journal/cciJCO Clinical Cancer Informatics
https://ascopubs.org/journal/poJCO Precision Oncology
https://ascopubs.org/journal/oaJCO Oncology Advances
https://ascopubs.org/journal/edbkASCO Educational Book
https://dailynews.ascopubs.org/Externo Subdominio ASCO Daily News
https://connection.asco.org/Nueva ventana Externo Subdominio ASCO Connection
https://ascopost.com/Nueva ventana Externo The ASCO Post
https://ascopubs.org/topicsTopics
https://ascopubs.org/subscribeSubscribe
https://ascopubs.org/authorsAuthors
/about/asco-journalsAbout
https://careercenter.asco.org/...Nueva ventana Externo Subdominio Careers
https://jcoresourcecenter.asco...Externo Subdominio Breast Cancer
https://jcoresourcecenter.asco...Externo Subdominio Non–Small Cell Lung Cancer
https://jcoresourcecenter.asco...Externo Subdominio Renal Cell Carcinoma
https://ascopubs.org/Texto ancla Search
/action/showCart?FlowID=10 Cart
A-TITLE Show shopping cart
https://signin.asco.org/oauth2...Externo Subdominio Log in
https://www.asco.org/membershipNueva ventana Externo Subdominio become a member
https://ascopubs.org/Texto ancla Anywhere
https://ascopubs.org/Texto ancla Citation
/search/advancedAdvanced Search
/action/doSearch?AllField=kidn...Kidney Cancer
/action/doSearch?AllField=work...Workforce
/action/doSearch?AllField=brea...Texto duplicado Breast Cancer
/action/doSearch?AllField=germ...Germline
/action/doSearch?AllField=mach...Machine Learning
https://ascopubs.org/Texto ancla Sin texto
https://signin.asco.org/oauth2...Externo Subdominio Texto duplicado Log in
https://www.asco.org/membershipNueva ventana Externo Subdominio Texto duplicado become a member
https://ascopubs.org/ascopubs.org
https://ascopubs.org/authorsSubmit
https://ascopubs.org/Texto ancla Sin texto
http://www.asco.org/Externo Subdominio IMG-ALT American Society of Clinical Oncology (ASCO)
/doi/10.1200/JCO-24-01365Reply to M. Boileau et al
/author/Barker,+Christopher+AChristopher A. Barker et al.
A-TITLE articles by this author
/doi/10.1200/JCO.23.02503Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
/author/Wirth,+Lori+JLori J. Wirth et al.
A-TITLE articles by this author
/doi/10.1200/JCO.23.02786Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
/author/Jain,+Michael+DMichael D. Jain et al.
A-TITLE articles by this author
/doi/10.1200/JCO.24.00347Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality
/author/Venkataraman,+VinayakVinayak Venkataraman et al.
A-TITLE articles by this author
/doi/10.1200/JCO.24.01042Neoadjuvant Sonic Hedgehog Inhibitors Combined With Radiotherapy Is a Promising Strategy for Locally Advanced Basal Cell Carcinoma
/author/Boileau,+MarieMarie Boileau et al.
A-TITLE articles by this author
/doi/10.1200/OP-24-00501Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations
/author/Gupta,+ArjunArjun Gupta et al.
A-TITLE articles by this author
/doi/10.1200/CCI.23.00234Cureit: An End-to-End Pipeline for Implementing Mixture Cure Models With an Application to Liposarcoma Data
/author/Whiting,+KarissaKarissa Whiting et al.
A-TITLE articles by this author
/doi/10.1200/JCO-24-01487Sex-based Differences in Risk for Therapy-related Myeloid Neoplasms
/author/Richard,+Melissa+AMelissa A Richard et al.
A-TITLE articles by this author
https://ascopubs.org/Texto ancla Skip slideshow
/jcooncologyadvancesASCO Launches New Open Access Journal JCO Oncology Advances
https://ascopubs.org/topicsStay on Top of Your Specialty with JCO Topics
https://ascopubs.org/Texto ancla Trending Articles
https://ascopubs.org/Texto ancla MOST CITED
/doi/10.1200/JCO.21.01440Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
/author/Schneider,+Bryan+JBryan J. Schneider et al.
A-TITLE articles by this author
/doi/10.1200/JCO.24.00581Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
/author/Solomon,+Benjamin+JBenjamin J. Solomon et al.
A-TITLE articles by this author
/doi/10.1200/JCO.23.02170Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 5-Year Results...
/author/Tarantino,+PaoloPaolo Tarantino et al.
A-TITLE articles by this author
/doi/10.1200/JCO.23.01994Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: ...
/author/Rastogi,+PriyaPriya Rastogi et al.
A-TITLE articles by this author
/doi/10.1200/JCO.23.02005Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
/author/Meric-Bernstam,+FundaFunda Meric-Bernstam et al.
A-TITLE articles by this author
/doi/10.1200/JCO.24.00662Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline
/author/Tung,+NadineNadine Tung et al.
A-TITLE articles by this author
/doi/10.1200/JCO.2013.54.8800Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
/author/Cheson,+Bruce+DBruce D. Cheson et al.
A-TITLE articles by this author
/doi/10.1200/JCO.19.02105Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-...
/author/Marabelle,+AurelienAurelien Marabelle et al.
A-TITLE articles by this author
/doi/10.1200/JCO.2017.77.6385Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Prac...
/author/Brahmer,+Julie+RJulie R. Brahmer et al.
A-TITLE articles by this author
/doi/10.1200/JCO.2007.12.9791How To Build and Interpret a Nomogram for Cancer Prognosis
/author/Iasonos,+AlexiaAlexia Iasonos et al.
A-TITLE articles by this author
/doi/10.1200/JCO.2018.77.8738Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice G...
/author/Wolff,+Antonio+CAntonio C. Wolff et al.
A-TITLE articles by this author
/doi/10.1200/JCO.2014.57.9151Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
/author/Johnson,+Philip+JPhilip J. Johnson et al.
A-TITLE articles by this author
/do/jco-precision-oncology-art...A-TITLE JCO PO Article Insights: Statistical Considerations for Biomarker-Driven Oncology Clinical Trials
/do/jco-precision-oncology-art...Texto duplicado JCO PO Article Insights: Statistical Considerations for Biomarker-Driven Oncology Clinical Trials
/action/doSearch?field1=Contri...Dr. Miki Horiguchi
A-TITLE articles by this author
/do/jco-article-insights-back-...A-TITLE JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
/do/jco-article-insights-back-...Texto duplicado JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
/do/mattered-later-patient-tur...A-TITLE It Mattered Later: A Patient Turned Doctor's Perspective on Fertility Loss
/do/mattered-later-patient-tur...Texto duplicado It Mattered Later: A Patient Turned Doctor's Perspective on Fertility Loss
/action/doSearch?field1=Contri...Dr. Lidia Schapira
A-TITLE articles by this author
/action/doSearch?field1=Contri...Dr. Margaret Cupit-Link
A-TITLE articles by this author
/do/management-stage-iii-nsclc...A-TITLE Management of Stage III NSCLC Rapid Update
/do/management-stage-iii-nsclc...Texto duplicado Management of Stage III NSCLC Rapid Update
/action/doSearch?field1=Contri...Brittany Harvey
A-TITLE articles by this author
/action/doSearch?field1=Contri...Dr. Megan Daly
A-TITLE articles by this author
https://ascopubs.org/podcastsVIEW ALL PODCASTS
/journal/jco/podcastIMG-ALT Journal of Clinical Oncology Podcast
/journal/jco/cancer-stories-po...IMG-ALT Cancer Stories: The Art of Oncology podcast
/journal/po/podcastIMG-ALT JCO Precision Oncology Conversations podcast
/journal/jco/asco-guidelines-p...IMG-ALT ASCO Guidelines podcast
https://old-prod.asco.org/abou...Nueva ventana Externo Subdominio Read More About ASCO
/toc/jco/currentAugust 1, 2024 Volume 42Issue 22
IMG-ALT August 1, 2024 Volume 42 Issue 22
A-TITLE August 1, 2024 Volume 42 Issue 22
/toc/jco/currentTexto duplicado August 1, 2024 Volume 42Issue 22
/toc/op/currentJuly 2024 Volume 20Issue 7
IMG-ALT July 2024 Volume 20 Issue 7
A-TITLE July 2024 Volume 20 Issue 7
/toc/op/currentTexto duplicado July 2024 Volume 20Issue 7
/toc/go/current2024 Volume 10
IMG-ALT 2024 Volume
A-TITLE 2024 Volume 10
/toc/go/currentTexto duplicado 2024 Volume 10
/toc/cci/current2024 Volume 8
IMG-ALT 2024 Volume 8
A-TITLE 2024 Volume 8
/toc/cci/currentTexto duplicado 2024 Volume 8
/toc/po/currentTexto duplicado 2024 Volume 8
IMG-ALT 2024 Volume
A-TITLE 2024 Volume 8
/toc/po/currentTexto duplicado 2024 Volume 8
https://ascopubs.org/journal/edbkIMG-ALT ASCO Educational Book logo
A-TITLE Link to ASCO Educational Book
https://dailynews.ascopubs.org/Externo Subdominio IMG-ALT ASCO Daily News logo
A-TITLE Link to ASCO Daily News
https://connection.asco.org/Externo Subdominio IMG-ALT ASCO Connection logo
A-TITLE Link to ASCO Connection
https://ascopost.com/Externo IMG-ALT ASCO Post logo
A-TITLE Link to ASCO Post
/doi/10.1200/JCO.24.00347Texto duplicado Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality
/author/Venkataraman,+VinayakTexto duplicado Vinayak Venkataraman et al.
A-TITLE articles by this author
/doi/10.1200/GO.24.00184JCO Global Oncology Editorial on Resource-Stratified Guidelines
/author/Fadelu,+TemidayoTemidayo Fadelu et al.
A-TITLE articles by this author
/doi/10.1200/JCO.24.00961Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement
/author/Thota,+RamyaRamya Thota et al.
A-TITLE articles by this author
/topic/subject_thes/936View Access to Care
/doi/10.1200/JCO.24.00396Three Days Was Enough
/author/Thomas,+Teresa+HaganTeresa Hagan Thomas
A-TITLE articles by this author
/doi/10.1200/OP.23.00813Patterns of Survivorship Follow-Up Care Among Patients With Breast Cancer: A Retrospective Population-Based Cohort Study in Ontario, Canada, Between 2006 and...
/author/Sussman,+JonathanJonathan Sussman et al.
A-TITLE articles by this author
/doi/10.1200/OP.24.00215Fragmented Surgical Cancer Care—A Growing Divide
/author/Cham,+StephanieStephanie Cham et al.
A-TITLE articles by this author
/topic/subject_thes/132View Quality of Care
/doi/10.1200/JCO.1999.17.1.312Decision Analysis as an Aid to Determining the Management of Early Low Rectal Cancer for the Individual Patient
/author/Temple,+Larissa+K+FLarissa K.F. Temple et al.
A-TITLE articles by this author
/doi/10.1200/JCO.1999.17.1.319Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric Cancer
/author/Boku,+NarikazuNarikazu Boku et al.
A-TITLE articles by this author
/doi/10.1200/JCO.1999.17.1.324Recurrence Patterns of Hepatocellular and Fibrolamellar Carcinoma After Liver Transplantation
/author/Schlitt,+Hans+JHans J. Schlitt et al.
A-TITLE articles by this author
/topic/subject_thes/237View Gastrointestinal Cancers
https://ascopubs.org/topicsView All Topics
https://ascopubs.org/authorsLearn more
http://www.asco.org/Externo Subdominio Texto duplicado IMG-ALT American Society of Clinical Oncology (ASCO)
https://ascopubs.org/journal/jcoTexto duplicado Journal of Clinical Oncology
https://ascopubs.org/journal/opTexto duplicado JCO Oncology Practice
https://ascopubs.org/journal/goTexto duplicado JCO Global Oncology
https://ascopubs.org/journal/cciTexto duplicado JCO Clinical Cancer Informatics
https://ascopubs.org/journal/poTexto duplicado JCO Precision Oncology
https://ascopubs.org/journal/oaTexto duplicado JCO Oncology Advances
https://ascopubs.org/journal/edbkTexto duplicado ASCO Educational Book
https://dailynews.ascopubs.org/Externo Subdominio Texto duplicado ASCO Daily News
https://connection.asco.org/Externo Subdominio Texto duplicado ASCO Connection
https://ascopost.com/Externo Texto duplicado The ASCO Post
https://old-prod.asco.org/news...Externo Subdominio ASCO Podcasts
https://ascopubs.org/podcastsJournal Podcasts
https://ascopubs.org/topicsTexto duplicado Topics
https://ascopubs.org/jco/meetingMeeting Abstracts
/jco/special/guidelinesASCO Guidelines
https://ascopubs.org/authorsAuthor Center
https://ascopubs.org/subscribeSubscriber Center
/about/permissionsPermissions
/about/reprintsReprints
/about/advertiseAdvertise
https://apps.asco.org/EmailPre...Externo Subdominio E-Alerts
/action/showPreferencesView My Profile
/about/asco-journalsAbout ASCO Journals
https://twitter.com/JCO_ASCOExterno JCO_ASCO
https://twitter.com/JCOOP_ASCOExterno JCOOP_ASCO
https://twitter.com/JCOGO_ASCOExterno JCOGO_ASCO
https://twitter.com/JCOPO_ASCOExterno JCOPO_ASCO
https://twitter.com/JCOCCI_ASCOExterno JCOCCI_ASCO
https://old-prod.asco.org/abou...Externo Subdominio About ASCO
https://old-prod.asco.org/abou...Externo Subdominio Press Center
https://old-prod.asco.org/meet...Externo Subdominio Meetings & Education
https://old-prod.asco.org/cont...Externo Subdominio Contact Us
https://asco.org/Externo asco.org
https://careercenter.asco.org/...Nueva ventana Externo Subdominio ASCO Career Center
https://www.conquer.org/Externo Subdominio Conquer Cancer
http://www.asco.org/Nueva ventana Externo Subdominio American Society of Clinical Oncology
A-TITLE American Society of Clinical Oncology (ASCO)
https://ascopubs.org/sitemapNueva ventana Site Map
https://www.asco.org/about-asc...Nueva ventana Externo Subdominio Terms of Use
https://www.asco.org/about-asc...Nueva ventana Externo Subdominio Privacy Policy

Configuración del servidor

Redirecciones HTTP
(Extremadamente importante)
Esta página redirige a "https://ascopubs.org/".
Cabecera HTTP
(Importante)
La cabecera X-Powered-by no se envía en la cabecera de la página.
Esta página utiliza GZip para la transmisión de datos comprimidos.
Rendimiento
(Poco importante)
Con 1,15 segundos, el tiempo de respuesta de la página es superior al límite recomendado de 0,4 segundos. Un tiempo de respuesta elevado ralentiza innecesariamente el rastreo de los buscadores y propicia una mala experiencia de uso.
El tamaño HTML de la página es adecuado: 112 kB.

Cabecera HTTP

NombreValor
dateMon, 05 Aug 2024 06:06:23 GMT
content-typetext/html;charset=UTF-8
x-xss-protection1; mode=block
x-content-type-optionsnosniff
strict-transport-securitymax-age=15552000
x-frame-optionsSAMEORIGIN
set-cookie69 Caracteres
p3pCP="NOI DSP ADM OUR IND OTC"
cache-controlno-cache
x-webstats-respidb78576cc7b546f5cde95d2023ae9dc7d
link</products/asco/releasedAssets/css/build-3148ce91e5d710e12e9f.css>; rel=preload; as=style
cf-cache-statusDYNAMIC
servercloudflare
cf-ray8ae499d68a8e3a3e-FRA
content-encodinggzip
alt-svch3=":443"; ma=86400
statuscode200
http_versionHTTP/2

Factores externos

Listas negras
(Deseable)
Esta página no está clasificada como “contenido para adultos”.
Wikipedia enlaza esta página en sus fuentes.
Esta página recibe enlaces de calidad de otros sitios web.
Esta página recibe backlinks de 15.939 dominios de referencia.
Esta página recibe un total de 804.080 backlinks.
Esta página recibe backlinks de 10.482 direcciones IP distintas.
Popularidad en Facebook
(Poco importante)
Esta página tiene 0 compartir y comentarios en Facebook.

Robots.txt

Sitemap: https://ascopubs.org/sitemap-index-1.xml
User-agent: *
Disallow: /action
Disallow: /help
Disallow: /search
Disallow: /feedback
Disallow: /rss
Disallow: /page/account-confirmation-thanks
Disallow: /media
Disallow: /medical-research
Disallow: /servlet/linkout
Disallow: /doi/mlt/
Disallow: /topic
Disallow: /author/
Disallow: /doi/metrics/
Disallow: /authored-by/
Disallow: /history/
Allow: /action/showJournal
Allow: /action/showPublications
Allow: /action/showXml
Allow: /action/showTopic
Allow: /action/showBook
Allow: /action/showCoverImage

User-agent: facebookexternalhit
User-agent: LinkedInBot
User-agent: Twitterbot
Allow: /

User-agent: GPTBot
Disallow: /

User-agent: ChatGPT-User
Disallow: /

User-agent: CCBot
Disallow: /

Crawl-delay: 1

Snippet (vista previa de los resultados de búsqueda)

ascopubs.org
ASCO Publications

Palabras clave más importantes

Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.

Palabra claveResultadoComprobar
ASCO81%Check
ASCO publications66%Check
ASCO Guidelines63%Check
Oncology58%Check
Clinical58%Check
Clinical Oncology58%Check
Society56%Check
American56%Check
American Society56%Check
JCO Oncology52%Check

¡Analiza ya gratis hasta 1.000 páginas de ascopubs.org!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Política de cookies

Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.

Utilizamos estas cookies para que el sitio funcione correctamente

Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web

Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses